Lipitor Plaintiffs May Require Product Liability Lawsuit Funding
A federal judicial panel recently denied a request to centralize all pending Lipitor lawsuits into Multidistrict Litigation (MDL), citing the limited number of cases that allege a link between Lipitor and Type 2 Diabetes. Now faced with a potentially prolonged litigation process, some Lipitor plaintiffs may now be considering product liability lawsuit funding to help them keep afloat financially until… Read more »
How Do You Qualify for Pre Settlement Lawsuit Funding?
Have you suffered a personal injury or proven damages and are waiting compensation from a pending lawsuit? If you need cash today to help cover general living expenses and medical bills, but are uncertain if you qualify for legal loans, read on to learn more about eligibility for pre settlement lawsuit funding. LawStreet Capital makes the entire process easy and… Read more »
Why Sell Structured Settlement Plans?
Structured settlements are becoming an increasingly common way for people who have been injured to receive compensation payments. In addition to providing ongoing income, structured settlements guard against the financial risks faced by many plaintiffs who receive large lawsuit settlement sums. In some states, individuals can sell their rights to periodic payments to a company that will pay out a… Read more »
Studies Show Pradaxa May Increase Heart Attack Risk
Pradaxa (dabigatran) is a blood thinner intended to reduce the risk of stroke in patients with atrial fibrillation, a heart condition. However, recent studies indicate that the use of Pradaxa could significantly increase the risk of a heart attack. In fact, many patients have alleged serious side effects from the drug. Many of these patients have filed lawsuits against manufacturer… Read more »
Botched Da Vinci Robot Surgeries Impact Intuitive Surgical Stocks, Spark Litigation
Intuitive Surgical –manufacturer and marketer of the da Vinci surgical robot – reported flagging sales of its high-tech system, with quarter earnings down nearly $15 million compared to last year. Rising concerns over the safety and efficacy of its flagship product, along with a growing number of da Vinci surgical robot lawsuits, have made a substantial dent in the company’s… Read more »
